This study, performed to assess the prevalence and clinical implications of metabolic syndrome (MetS) in patients with primary antiphospholipid syndrome (pAPS), involved 71 patients with pAPS and 73 age-matched controls. 33.8% of patients with pAPS in this study also had MetS, and these patients had a higher risk of arterial events and cardiovascular risk factors than patients with pAPS alone. The authors conclude that co-existant MetS might exacerbate endothelial abnormalities of pAPS.
ORIGINAL RESEARCH PAPER
Rodrigues, C. E. et al. Coexistence of metabolic syndrome and primary antiphospholipid syndrome is associated with arterial events. Arthritis Care Res. (Hoboken) doi:10.1002/acr.21701
Rights and permissions
About this article
Cite this article
Risk of arterial events in patients with primary APS. Nat Rev Rheumatol 8, 306 (2012). https://doi.org/10.1038/nrrheum.2012.71
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2012.71